收藏切换
Analysis of biological sample management issues and recommendations for improvement in Phase I clinical trial laboratories
收藏切换
PDF
Xue-lan HE, Yi ZHAO, Yan LEI, Wei-tong LIN, Xu YANG, Kai-peng HUANG
Chinese Journal of Clinical Pharmacology | 2025, 41(22) : 3296 - 3300
Less
收藏切换
Chinese Journal of Clinical Pharmacology | 2025, 41(22): 3296-3300
Special Column of Clinical Trials Administration
Analysis of biological sample management issues and recommendations for improvement in Phase I clinical trial laboratories
Full
Xue-lan HE, Yi ZHAO, Yan LEI, Wei-tong LIN, Xu YANG, Kai-peng HUANG
Affiliations
  • Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou 510060, Guangdong Province, China
Published: 2025-11-28 doi: 10.13699/j.cnki.1001-6821.2025.22.022
Outline
收藏切换
Objective

To examine issues in sample management within drug clinical trials, their implications on subject rights, data integrity, and propose targeted enhancements.

Methods

A retrospective analysis was conducted on 69 clinical trial projects, encompassing bioequivalence and innovative drug phase I-IV trials, processed by the phase I clinical trial laboratory at our institution from April 2018 to December 2024. Problems in biological sample management were identified through monitoring records maintained by quality control professionals, institutional quality control personnel, and clinical research monitors. The distribution patterns of issues were analyzed, and non-standard problems were assessed and categorized using the protocol deviation (PD) evaluation system.

Results

A total of 68 issues were identified in biological sample management, primarily centered around sample collection (27.94%), processing (19.12%), and preservation (36.76%). PD evaluations indicated that deficiencies in operational processes (e.g., non-compliance with standard operating procedures), insufficient personnel training, and irregular documentation were the primary underlying causes.

Conclusion

Comprehensive standardized management strategies, including enhancing standardized procedures in critical stages, improving personnel training, quality control frameworks, and implementing intelligent information systems, are essential to ensure the provision of dependable sample support for high-caliber clinical research.

drug clinical trial  /  biological sample management  /  protocol deviations
Xue-lan HE, Yi ZHAO, Yan LEI, Wei-tong LIN, Xu YANG, Kai-peng HUANG. Analysis of biological sample management issues and recommendations for improvement in Phase I clinical trial laboratories[J]. Chinese Journal of Clinical Pharmacology, 2025 , 41 (22) : 3296 -3300 . DOI: 10.13699/j.cnki.1001-6821.2025.22.022
Year 2025 volume 41 Issue 22
PDF
301
171
Cite this Article
BibTeX
Article Info
doi: 10.13699/j.cnki.1001-6821.2025.22.022
  • Receive Date:2025-07-03
  • Online Date:2026-08-05
  • Published:2025-11-28
Article Data
Affiliations
History
  • Received:2025-07-03
Affiliations
    Guangzhou Eighth People’s Hospital, Guangzhou Medical University, Guangzhou 510060, Guangdong Province, China
References
Share
https://castjournals.cast.org.cn/joweb/zglcylxzz/EN/10.13699/j.cnki.1001-6821.2025.22.022
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT